Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main
Gerhard Hessler is head of the group “Computational Structural Drug Design” at Sanofi-Aventis Deutschland GmbH in Frankfurt. The research group applies computational methods as well as experimental approaches like biophysical measurement and x-ray crystallography to the identification of novel lead structures and subsequent lead optimization.
Before, Gerhard Hessler was responsible for structural biology for more than a year and for a group in computer-aided drug design for about 4 years. He joined Aventis in 2001 as computational chemist, after working for four years in the computational chemistry group at the Central Research at Bayer AG.
Gerhard Hessler did his Ph.D. at the Technical University of Munich in NMR-based conformational analysis of biologically active peptides and oligonucleotides. During his industrial career, the main focus of his work is the application of ligand- and structure-based design techniques to the development of drugs.He has published more than 30 scientific articles and reviews and contributed to more than 20 patents.